Optinose Reports Financial Dip Despite Potential Breakthrough in Chronic Sinusitis Treatment
YARDLEY, PA — Optinose (NASDAQ: OPTN), has released its financial results for the quarter and year ending December 31, 2023. The report indicates a slight dip in revenue, but highlights …
Optinose Reports Financial Dip Despite Potential Breakthrough in Chronic Sinusitis Treatment Read More